APS (Autologous Protein Solution) Injection Singapore

APS injections may be recommended for patients suffering from various conditions that have not responded adequately to conventional treatments.

• Knee Osteoarthritis: Patients with mild to moderate knee osteoarthritis who experience persistent pain despite conservative management may benefit from APS therapy. The injection can help address the inflammatory component of osteoarthritis.
• Hip Osteoarthritis: Individuals with degenerative changes in the hip joint who wish to delay surgical intervention might be candidates for APS injections. The treatment targets the inflammatory process in the hip joint.
• Shoulder Arthritis: Patients with glenohumeral joint arthritis experiencing pain and limited function may receive APS injections. The concentrated proteins work to modulate inflammation within the shoulder joint.
• Tendon Injuries: Chronic tendinopathies, such as tennis elbow or Achilles tendinopathy, that have not resolved with rest and physical therapy may respond to APS therapy. The growth factors in APS can support tissue repair processes.
• Post-Traumatic Arthritis: Joints that have developed arthritis following an injury or trauma may be treated with APS injections. The biological treatment can help manage symptoms in these affected joints.

APS injection therapy offers several advantages for patients seeking non-surgical management of their conditions.

• Utilisation of the Body’s Own Healing Factors
  APS therapy leverages the patient’s own biological materials to promote healing. The concentrated solution contains proteins that can help modulate inflammation and support tissue repair.
• Minimally Invasive Approach
  The procedure requires only needle insertion and avoids the need for surgical incisions. Patients can typically return to their normal activities within a day of receiving the injection.
• Reduced Medication Dependence
  Many patients report decreased reliance on pain medications following APS treatment. The biological approach may provide longer-lasting relief compared to oral anti-inflammatory drugs.
• Potential to Delay Surgery
  For patients with early to moderate joint degeneration, APS injections may postpone the need for more invasive surgical procedures. The therapy aims to address symptoms while preserving joint function.
• Targeted Treatment
  The injection delivers therapeutic proteins directly to the affected area. This localised delivery system allows for concentrated action at the site of inflammation or tissue damage.

Medical Assessment

A comprehensive evaluation determines if the patient is a suitable candidate for APS therapy. This assessment includes reviewing medical history, examining the affected joint, and possibly ordering diagnostic imaging to assess joint condition.

Medication Review

Certain medications, particularly blood thinners and non-steroidal anti-inflammatory drugs, may need to be temporarily discontinued before the procedure. The patient will be advised on which medications to adjust and when these changes should be made.

Hydration Guidelines

Patients are advised to be well-hydrated before the procedure to facilitate blood collection. Drinking plenty of water in the 24 hours before the appointment helps ensure adequate blood volume for processing.